| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |